Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Khattar Jack A.
Relationship:   Director
City:   Rockville
State:   MD
   
Insider Summary:
  
   
Companies Owned :   4    
Direct Shares   1,370,341    

Indirect Shares

   2,118,700      
Direct Value   $24,820,685    

Indirect Value

   $27,728,844      
Total Shares   3,489,041      
Total Value   $52,549,529      


Supernus Pharmaceuticals Inc $24,820,685 Tesaro, Inc. $0 Scpharmaceuticals Inc. $0 Cognition Therapeutics Inc $0 Supernus Pharmaceuticals Inc $24,820,685 Tesaro, Inc. $0 Scpharmaceuticals Inc. $0 Cognition Therapeutics Inc $0
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    0   
    1    

     Stock price went up :
    0   
    0    
     Stock price went down :
    0   
    1    
   
     Gain/Loss Ratio :
   0.0   
   -1.0   
     Percentage Gain/Loss :
     0.0%
 -42.9%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Supernus Pharmaceuticals Inc SUPN President, CEO, Director 2024-02-28 915,217 2024-02-28 1,022,450    Premium*  
            Tesaro, Inc. TSRO President, CEO, Director 2016-03-29 444,124 2016-03-29 1,096,250    Premium*  
            Scpharmaceuticals Inc. SCPH Director 2021-12-03 5,000 2021-12-03 0    Premium*  
            Cognition Therapeutics Inc CGTX Director 2023-06-09 6,000 2023-06-09 0    Premium*  
* Premium Members only  

Records found :    98         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 3 of 4
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
SUPN Supernus Pharmaceuticals ... President, CEO   •       •      –    2022-08-16 4 AS $34.01 $499,651 D/D (14,690) 775,559 0 %
SUPN Supernus Pharmaceuticals ... President, CEO   •       •      –    2022-09-14 4 OE $33.75 $46,575 D/D 1,380 780,074 0 -
SUPN Supernus Pharmaceuticals ... President, CEO   •       •      –    2022-09-14 4 OE $0.00 $0 D/D 5,895 781,454 0 -
SUPN Supernus Pharmaceuticals ... President, CEO   •       •      –    2022-11-15 4 OE $9.56 $17,045 D/D 1,783 781,857 0 -
SUPN Supernus Pharmaceuticals ... President, CEO   •       •      –    2022-11-15 4 AS $35.00 $39,028 D/D (1,115) 780,742 0 %
SUPN Supernus Pharmaceuticals ... President, CEO   •       •      –    2022-11-21 4 AS $35.01 $18,592 D/D (531) 781,059 0 %
SUPN Supernus Pharmaceuticals ... President, CEO   •       •      –    2022-11-21 4 OE $9.56 $8,107 D/D 848 781,590 0 -
SUPN Supernus Pharmaceuticals ... President, CEO   •       •      –    2022-11-22 4 OE $9.56 $9,168 D/D 959 782,018 0 -
SUPN Supernus Pharmaceuticals ... President, CEO   •       •      –    2022-11-22 4 AS $35.00 $21,001 D/D (600) 781,418 0 %
SUPN Supernus Pharmaceuticals ... President, CEO   •       •      –    2022-11-23 4 OE $9.56 $34,569 D/D 3,616 785,034 0 -
SUPN Supernus Pharmaceuticals ... President, CEO   •       •      –    2022-11-23 4 AS $35.05 $79,189 D/D (2,259) 782,775 0 %
SUPN Supernus Pharmaceuticals ... President, CEO   •       •      –    2022-11-25 4 AS $35.18 $391,685 D/D (11,135) 789,434 0 %
SUPN Supernus Pharmaceuticals ... President, CEO   •       •      –    2022-11-25 4 OE $9.56 $170,111 D/D 17,794 800,569 0 -
SUPN Supernus Pharmaceuticals ... President, CEO   •       •      –    2022-12-20 4 OE $9.56 $62,408 D/D 6,528 795,962 0 -
SUPN Supernus Pharmaceuticals ... President, CEO   •       •      –    2022-12-20 4 AS $38.02 $152,317 D/D (4,006) 791,956 0 %
SUPN Supernus Pharmaceuticals ... President, CEO   •       •      –    2022-12-21 4 A $0.00 $0 D/D 15,625 807,581 0 -
SUPN Supernus Pharmaceuticals ... President, CEO   •       •      –    2022-12-21 4 OE $9.56 $176,592 D/D 18,472 826,053 0 -
SUPN Supernus Pharmaceuticals ... President, CEO   •       •      –    2022-12-21 4 AS $38.14 $433,070 D/D (11,354) 814,699 0 %
SUPN Supernus Pharmaceuticals ... President, CEO   •       •      –    2023-01-17 4 OE $9.56 $400,755 D/D 41,920 816,619 0 -
SUPN Supernus Pharmaceuticals ... President, CEO   •       •      –    2023-01-17 4 AS $40.03 $1,018,728 D/D (25,446) 791,173 0 %
SUPN Supernus Pharmaceuticals ... President, CEO   •       •      –    2023-01-18 4 AS $40.40 $199,394 D/D (4,936) 794,317 0 %
SUPN Supernus Pharmaceuticals ... President, CEO   •       •      –    2023-01-18 4 OE $9.56 $77,245 D/D 8,080 799,253 0 -
SUPN Supernus Pharmaceuticals ... President, CEO   •       •      –    2023-01-31 4 AS $42.01 $41,002 D/D (976) 794,961 0 %
SUPN Supernus Pharmaceuticals ... President, CEO   •       •      –    2023-01-31 4 OE $9.56 $15,487 D/D 1,620 795,937 0 -
SUPN Supernus Pharmaceuticals ... President, CEO   •       •      –    2023-02-01 4 AS $42.01 $12,602 D/D (300) 795,159 0 %
  98  Records found
  1   2   3  4      
  Page 3 of 4  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us